Cns Pharmaceuticals, Inc.盘中异动股价大跌9.31%

市场透视2025-02-21

北京时间2025年02月21日22时35分，Cns Pharmaceuticals, Inc.（CNSP.us）股票出现异动，股价快速下挫9.31%。截至发稿，该股报3.40美元/股，成交量8.3068万股，换手率5.54%，振幅10.65%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-5.61百万美元，每股收益-0.25美元，毛利-751.00美元，市盈率0.00倍。机构评级方面，...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2513296342?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-02-21 22:35","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2513296342","market":"us","top_or_hot":-1,"title":"Cns Pharmaceuticals, Inc.盘中异动 股价大跌9.31%","media":"市场透视","content":"<div>\n<p>北京时间2025年02月21日22时35分，Cns Pharmaceuticals, Inc.（CNSP.us）股票出现异动，股价快速下挫9.31%。截至发稿，该股报3.40美元/股，成交量8.3068万股，换手率5.54%，振幅10.65%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-5.61百万美元，每股收益-0.25美元，毛利-751.00美元，市盈率0.00倍。机构评级方面，...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223509962b7c0e&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cns Pharmaceuticals, Inc.盘中异动 股价大跌9.31%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCns Pharmaceuticals, Inc.盘中异动 股价大跌9.31%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-02-21 22:35 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223509962b7c0e&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年02月21日22时35分，Cns Pharmaceuticals, Inc.（CNSP.us）股票出现异动，股价快速下挫9.31%。截至发稿，该股报3.40美元/股，成交量8.3068万股，换手率5.54%，振幅10.65%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-5.61百万美元，每股收益-0.25美元，毛利-751.00美元，市盈率0.00倍。机构评级方面，...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223509962b7c0e&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223509962b7c0e&s=b","article_id":"2513296342","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223509962b7c0e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2513296342","pubTimestamp":1740148509,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年02月21日22时35分，Cns Pharmaceuticals, Inc.股票出现异动，股价快速下挫9.31%。Cns Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。Cns Pharmaceuticals, Inc.公司简介：CNS Pharmaceuticals Inc 是一家临床阶段制药公司，专注于开发用以治疗原发性和转移性脑及中枢神经系统肿瘤的抗癌候选药物。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4007":"制药","CNSP":"CNS Pharmaceuticals, Inc."},"translate_title":"Cns Pharmaceuticals, Inc. shares plunged 9.31% during intraday changes","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CNSP":0.9},"content_text":"北京时间2025年02月21日22时35分，Cns Pharmaceuticals, Inc.（CNSP.us）股票出现异动，股价快速下挫9.31%。截至发稿，该股报3.40美元/股，成交量8.3068万股，换手率5.54%，振幅10.65%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-5.61百万美元，每股收益-0.25美元，毛利-751.00美元，市盈率0.00倍。机构评级方面，在所有2家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Cns Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。其相关个股中，Osr Holdings, Inc.、Osr Holdings Inc C/Wts 09/02/2028 (To Pur Com)、Omega Therapeutics, Inc.涨幅较大，Nkgen Biotech, Inc.、Aditxt, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为72.20%、64.54%、15.57%，振幅较大的相关个股有Lexaria Bioscience Corp C/Wts 14/01/2026 (To Pur Com)、Osr Holdings Inc C/Wts 09/02/2028 (To Pur Com)、Omega Therapeutics, Inc.，振幅分别为33.83%、30.00%、22.47%。Cns Pharmaceuticals, Inc.公司简介：CNS Pharmaceuticals Inc 是一家临床阶段制药公司，专注于开发用以治疗原发性和转移性脑及中枢神经系统肿瘤的抗癌候选药物。 该公司参与了 Berubicin 的开发，它是一种治疗胶质母细胞瘤的疗法。 胶质母细胞瘤是由星形胶质细胞产生的肿瘤，而星形胶质细胞是构成大脑支持组织的星形细胞。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2513296342","isCrawlerRequest":true}

Cns Pharmaceuticals, Inc.盘中异动 股价大跌9.31%

精彩评论

Cns Pharmaceuticals, Inc.盘中异动股价大跌9.31%